Phase 2, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of SAR443820 in adult participants with amyotrophic lateral sclerosis, followed by an open-label extension

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Eligibility

Age 18-80 Diagnosis: ALS Onset of ALS symptoms less than 24 months ago Able to swallow pills

Type of Study

Treatment

Locations

Outpatient CTRC
University of Colorado Hospital

Principal Investigator
Photograph of Thomas Ragole,  MD

Thomas Ragole, MD

Study ID

Protocol Number: 22-0037

More information available at ClinicalTrials.gov: NCT05237284

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers